Pegasys Market Position Secure, Roche Says; Dismisses PEG-Intron Data
Executive Summary
Roche expects to have firmly established its leadership position in the hepatitis C market with Pegasys by the time Schering-Plough publishes the results from its ongoing head-to-head study versus PEG-Intron